Cargando…
Vasopressor Therapy and the Brain: Dark Side of the Moon
Sepsis, a leading cause of morbidity and mortality, is caused by a deregulated host response to pathogens, and subsequent life-threatening organ dysfunctions. All major systems, including the cardiovascular, respiratory, renal, hepatic, hematological, and the neurological system may be affected by s...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966606/ https://www.ncbi.nlm.nih.gov/pubmed/31998736 http://dx.doi.org/10.3389/fmed.2019.00317 |
_version_ | 1783488774732251136 |
---|---|
author | Heming, Nicholas Mazeraud, Aurélien Azabou, Eric Moine, Pierre Annane, Djillali |
author_facet | Heming, Nicholas Mazeraud, Aurélien Azabou, Eric Moine, Pierre Annane, Djillali |
author_sort | Heming, Nicholas |
collection | PubMed |
description | Sepsis, a leading cause of morbidity and mortality, is caused by a deregulated host response to pathogens, and subsequent life-threatening organ dysfunctions. All major systems, including the cardiovascular, respiratory, renal, hepatic, hematological, and the neurological system may be affected by sepsis. Sepsis associated neurological dysfunction is triggered by multiple factors including neuro-inflammation, excitotoxicity, and ischemia. Ischemia results from reduced cerebral blood flow, caused by extreme variations of blood pressure, occlusion of cerebral vessels, or more subtle defects of the microcirculation. International guidelines comprehensively describe the initial hemodynamic management of sepsis, revolving around the normalization of systemic hemodynamics and of arterial lactate. By contrast, the management of sepsis patients suffering from brain dysfunction is poorly detailed, the only salient point being mentioned is that sedation and analgesia should be optimized. However, sepsis and the hemodynamic consequences thereof as well as vasopressors may have severe untoward neurological consequences. The current review describes the general neurological complications, as well as the consequences of vasopressor therapy on the brain and its circulation and addresses methods for cerebral monitoring during sepsis. |
format | Online Article Text |
id | pubmed-6966606 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-69666062020-01-29 Vasopressor Therapy and the Brain: Dark Side of the Moon Heming, Nicholas Mazeraud, Aurélien Azabou, Eric Moine, Pierre Annane, Djillali Front Med (Lausanne) Medicine Sepsis, a leading cause of morbidity and mortality, is caused by a deregulated host response to pathogens, and subsequent life-threatening organ dysfunctions. All major systems, including the cardiovascular, respiratory, renal, hepatic, hematological, and the neurological system may be affected by sepsis. Sepsis associated neurological dysfunction is triggered by multiple factors including neuro-inflammation, excitotoxicity, and ischemia. Ischemia results from reduced cerebral blood flow, caused by extreme variations of blood pressure, occlusion of cerebral vessels, or more subtle defects of the microcirculation. International guidelines comprehensively describe the initial hemodynamic management of sepsis, revolving around the normalization of systemic hemodynamics and of arterial lactate. By contrast, the management of sepsis patients suffering from brain dysfunction is poorly detailed, the only salient point being mentioned is that sedation and analgesia should be optimized. However, sepsis and the hemodynamic consequences thereof as well as vasopressors may have severe untoward neurological consequences. The current review describes the general neurological complications, as well as the consequences of vasopressor therapy on the brain and its circulation and addresses methods for cerebral monitoring during sepsis. Frontiers Media S.A. 2020-01-10 /pmc/articles/PMC6966606/ /pubmed/31998736 http://dx.doi.org/10.3389/fmed.2019.00317 Text en Copyright © 2020 Heming, Mazeraud, Azabou, Moine and Annane. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Heming, Nicholas Mazeraud, Aurélien Azabou, Eric Moine, Pierre Annane, Djillali Vasopressor Therapy and the Brain: Dark Side of the Moon |
title | Vasopressor Therapy and the Brain: Dark Side of the Moon |
title_full | Vasopressor Therapy and the Brain: Dark Side of the Moon |
title_fullStr | Vasopressor Therapy and the Brain: Dark Side of the Moon |
title_full_unstemmed | Vasopressor Therapy and the Brain: Dark Side of the Moon |
title_short | Vasopressor Therapy and the Brain: Dark Side of the Moon |
title_sort | vasopressor therapy and the brain: dark side of the moon |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966606/ https://www.ncbi.nlm.nih.gov/pubmed/31998736 http://dx.doi.org/10.3389/fmed.2019.00317 |
work_keys_str_mv | AT hemingnicholas vasopressortherapyandthebraindarksideofthemoon AT mazeraudaurelien vasopressortherapyandthebraindarksideofthemoon AT azaboueric vasopressortherapyandthebraindarksideofthemoon AT moinepierre vasopressortherapyandthebraindarksideofthemoon AT annanedjillali vasopressortherapyandthebraindarksideofthemoon |